Nicholas Hornstein
@gimedonc
GI Med Oncologist @NorthwellHealth via Fellow@MDAndersonNews + IM@UCLAHealth
| CUMC ‘18 | Interests: Comp Biology, Clinical Trials, Colon Cancer, CUP
ID: 1324507882172248065
06-11-2020 00:24:38
488 Tweet
663 Takipçi
366 Takip Edilen
Pleased to announce the first trial to demonstrate benefit of systemic therapy in appendiceal cancer. Atezolizumab and Bevacizumab; significantly improved PFS compared to synthetic cohort. 🟢Median PFS 18.3 vs 4.4m. 🙇♂️Thanks to John Paul Shen and Kanwal Raghav 🩺 🖖🏻 for mentorship.